Partner Sharon Lamb will be speaking on the latest developments in life sciences regulation at the ABA’s 2018 Life Sciences Conference.
This session will explore present and likely future regulation on pricing of medicinal products, both US/EU domestically and in the context of export to developing countries. What are the mechanics of reimbursement of drug costs in the US and EU and what is their effect upon research and development of and access to new, innovative medicines?
For more information, please click here.
